Search

everythinglearnresearchcommunity

for

Search:↓

Combining two treatments for hair loss works better than using just one.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

The FDA rejected a testosterone drug again due to safety concerns.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Hair or fiber wrapped tightly around a toe can lead to serious injury if not treated quickly.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Injectable therapy, especially with dutasteride, may help with hair loss, but more research is needed.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Platelet- and marrow-derived biologics help heal tissues and reduce infections but need standardized methods for better use.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Early detection and treatment of hair-thread tourniquet syndrome in young girls is important to prevent serious harm.

Prescription and alternative therapies for hair loss will be compared for effectiveness.

Trichostasis spinulosa can be diagnosed with a simple skin biopsy and treated with specific gels, but lesions may return after stopping treatment.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

5-ARI therapy may help prevent prostate cancer progression.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Etanercept effectively treated a severe skin condition when other treatments failed.

Botulinum toxin Type A helps reduce hypertrophic scars and is generally safe.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Early diagnosis and treatment of TPP can prevent complications.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.